Franklin Resources
MRNA icon

Franklin Resources’s Moderna MRNA Stock Holding History

Franklin Resources’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
23,838
+1,311
+6% +$67.8K ﹤0.01% 2075
2026
Q1 		$1.14M Sell
22,527
-640
-3% -$29.9K ﹤0.01% 2132
2025
Q4 		$683K Sell
23,167
-13,825
-37% -$376K ﹤0.01% 2262
2025
Q3 		$956K Buy
36,992
+4,798
+15% +$134K ﹤0.01% 2121
2025
Q2 		$888K Buy
32,194
+878
+3% +$23.1K ﹤0.01% 2048
2025
Q1 		$888K Buy
31,316
+1,175
+4% +$41.7K ﹤0.01% 2014
2024
Q4 		$1.25M Sell
30,141
-602
-2% -$28.8K ﹤0.01% 1888
2024
Q3 		$1.77M Sell
30,743
-56,346
-65% -$5.17M ﹤0.01% 1782
2024
Q2 		$10.3M Buy
87,089
+54,861
+170% +$6.94M ﹤0.01% 1065
2024
Q1 		$3.43M Buy
32,228
+1,347
+4% +$136K ﹤0.01% 1507
2023
Q4 		$3.07M Sell
30,881
-566
-2% -$47.6K ﹤0.01% 1256
2023
Q3 		$3.25M Sell
31,447
-327,707
-91% -$36.6M ﹤0.01% 1216
2023
Q2 		$43.6M Sell
359,154
-270,031
-43% -$36M 0.02% 569
2023
Q1 		$96.6M Sell
629,185
-110,532
-15% -$18.2M 0.05% 375
2022
Q4 		$133M Buy
739,717
+158,183
+27% +$25.9M 0.07% 315
2022
Q3 		$68.8M Buy
581,534
+196,163
+51% +$29.8M 0.04% 451
2022
Q2 		$55M Buy
385,371
+6,042
+2% +$864K 0.03% 523
2022
Q1 		$65.3M Sell
379,329
-494,946
-57% -$83.3M 0.03% 525
2021
Q4 		$222M Sell
874,275
-101,684
-10% -$29.7M 0.08% 284
2021
Q3 		$376M Buy
975,959
+301,716
+45% +$111M 0.14% 183
2021
Q2 		$158M Buy
674,243
+403,892
+149% +$72.2M 0.06% 349
2021
Q1 		$35.4M Buy
270,351
+262,670
+3,420% +$38.1M 0.01% 707
2020
Q4 		$802K Buy
7,681
+610
+9% +$61.7K ﹤0.01% 1468
2020
Q3 		$500K Buy
+7,071
New +$493K ﹤0.01% 1493

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Franklin Resources's MRNA Position: Q2 2026 in Review

Franklin Resources increased its Moderna (MRNA) stake by 5.8% in Q2 2026, buying an estimated $67.8K and bringing the position to 23,838 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Franklin Resources first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $376M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Franklin Resources held 23,838 shares of Moderna worth $1.67M as of Q2 2026.
  • Franklin Resources bought 1,311 Moderna shares in Q2 2026, an estimated $67.8K.
  • Moderna made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2075 holding.
  • Franklin Resources first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
  • Franklin Resources's Moderna position peaked at $376M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.